Fujian Cosunter Pharmaceutical Co., Ltd.
300436.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$13B
Close$
$-18.45
123.8% downside
Current Fair Value
123.8% downsideOvervalued by 123.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $13.00 Billion |
|---|---|
| Enterprise Value | $13.31 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.37 |
| Beta | 1.17 |
| Outstanding Shares | 159,267,000 |
Return
| Return on Equity | -104.73% |
|---|---|
| Return on Assets | -16.38% |
| Return on Invested Capital | -23.48% |
Valuation & Multiples
| P/E Ratio | -56.48 |
|---|---|
| PEG | -537.33 |
| Price to Sales | 38.69 |
| Price to Book Ratio | 77.38 |
| Enterprise Value to Revenue | 31.3 |
| Enterprise Value to EBIT | -71.01 |
| Enterprise Value to Net Income | -61 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 2.28 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Fujian Cosunter Pharmaceutical Co., Ltd.
715 employees
CEO: Guoping Li Established in 2001 and headquartered in Fuzhou, China, Fujian Cosunter Pharmaceutical Co., Ltd. is a Chinese enterprise dedicated to the pharmaceutical industry. The company is actively involved in the full spectrum of pharmaceutical op...